URGE-PD: A Multi-Site, Double-Blind, Randomized, Placebo Controlled Trial of Solifenacin Succinate (VESIcare®) for the Treatment of Urinary Dysfunction in Parkinson's Disease

Research output: Other contributionOther

Original languageAmerican English
StatePublished - 2006

DC Disciplines

  • Epidemiology
  • Public Health

Cite this